A positive high-risk HPV test does not mean you have cancer. Most high-risk HPV infections, roughly 80% to 90%, clear on their own within two years without ever causing harm. What it does mean is that you need a clear plan for monitoring and, if necessary, treating any cell changes before they become a problem. Here’s what that plan looks like.
What High-Risk HPV Actually Means
There are 12 HPV types classified as high-risk: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. Two of these, HPV 16 and HPV 18, are responsible for most HPV-related cancers. “High-risk” refers to the potential these strains have to cause cell changes over time, not to any immediate danger. The virus can affect the cervix, throat, anus, vagina, vulva, and penis, but the vast majority of infections never progress that far.
The gap between infection and cancer is measured in years, sometimes a decade or more. That long timeline is exactly why screening and follow-up work so well. Precancerous changes are highly treatable when caught early, which is the entire point of the next steps your provider will recommend.
What Happens After a Positive Test
Your next step depends on which HPV type was detected, what your Pap results look like, and your screening history. Current guidelines use a risk-based approach: if your estimated chance of having significant precancerous changes (called CIN 3 or higher) is 4% or greater, you’ll be referred for a closer look through colposcopy. If that risk falls below 4%, your provider will typically recommend repeat testing in one year rather than an immediate procedure.
In practice, this means that if you tested positive for HPV 16 or 18 specifically, or if your Pap smear showed abnormal cells, you’re more likely to be sent for colposcopy soon. If your Pap was normal and you had a negative HPV test within the past few years, the risk is lower (around 2%), and watchful waiting with a repeat test in 12 months is the standard recommendation.
What to Expect During a Colposcopy
A colposcopy is not surgery. It’s a diagnostic exam that takes about 10 to 20 minutes in a clinic or office. Your provider uses a lighted magnifying instrument to get a close-up view of your cervix. A vinegar-like solution (dilute acetic acid) is applied to the cervix, which causes abnormal cells to temporarily turn white, making them visible. An iodine solution may also be used, since healthy tissue absorbs it and turns brown while abnormal areas stay lighter.
If anything looks abnormal, your provider will take a small tissue sample (biopsy) from the suspicious area using small forceps. You may feel a pinch or brief cramping. A solution is applied afterward to stop any minor bleeding. You’ll typically be asked to avoid tampons, intercourse, and vaginal medications for a short period while the biopsy site heals. Results usually come back within one to two weeks.
Understanding Biopsy Results
Biopsy results are graded by how deeply abnormal cells have spread into the tissue lining of the cervix. These grades determine what happens next.
- CIN 1 (low-grade): Abnormal cells affect only the lower third of the tissue lining. About 60% of CIN 1 cases return to normal on their own within a year. The standard approach is monitoring with repeat testing at one year. If CIN 1 persists beyond two years or worsens, treatment is recommended.
- CIN 2 (moderate): Abnormal cells extend deeper. This is considered a high-grade change and treatment is generally recommended, though younger patients (under 25) may be offered close observation instead.
- CIN 3 (severe): Abnormal cells span the full thickness of the tissue. Treatment is recommended to prevent progression to invasive cancer.
How Precancerous Cells Are Treated
For CIN 2 or CIN 3, the goal is to remove or destroy the abnormal tissue. The two most common approaches are an excisional procedure called LEEP and a freezing method called cryotherapy.
LEEP uses a thin, electrically heated wire loop to cut away the affected tissue. It’s done under local or short general anesthesia and also provides a tissue sample that can be examined further. Cryotherapy freezes the abnormal cells using a probe applied directly to the cervix, typically with a “double freeze” technique (three minutes of freezing, five minutes of thawing, then three more minutes of freezing). No anesthesia is needed.
Both procedures are effective. LEEP has a slightly higher overall cure rate at about 94% compared to 88% for cryotherapy, though the difference isn’t statistically significant for lower-grade changes. Where they diverge more meaningfully is with severe lesions: for CIN 3, LEEP cured 75% of cases compared to 67% for cryotherapy. Your provider will recommend one based on the severity and location of the changes. After either procedure, you’ll be asked to avoid intercourse, tampons, and vaginal products while healing, and you’ll have follow-up appointments at intervals over the next year.
What You Can Do to Help Your Body Clear the Virus
Since most HPV infections are cleared by your immune system, supporting that process matters. The single most impactful thing you can do is quit smoking if you smoke. Current smokers are roughly half as likely to clear an HPV infection compared to nonsmokers. The effect is dose-dependent: heavier smoking, longer duration, and more cigarettes per day all correlate with lower clearance rates. Smoking weakens the activity of immune cells that fight viral infections and is the most significant risk factor for cervical disease after HPV itself. Even passive smoke exposure has been linked to higher risk.
Beyond quitting smoking, the general principles of immune health apply: adequate sleep, regular physical activity, a diet rich in fruits and vegetables, and moderate alcohol intake. None of these are a cure, but they support the immune response your body is already mounting against the virus.
Whether the HPV Vaccine Still Helps
Yes, vaccination can still be beneficial even after a positive HPV test. The vaccine protects against multiple strains, so even if you’re already infected with one type, it can protect you against others you haven’t been exposed to. More notably, recent research shows that vaccination after treatment for HPV-related precancerous changes significantly reduces the risk of those changes coming back. Studies have documented this protective effect against recurrence after surgical treatment for high-grade cervical, vulvar, and genital lesions.
The vaccine doesn’t replace treatment. If you have precancerous changes that need a procedure, that still needs to happen. But getting vaccinated afterward (or at any point if you haven’t been) adds a layer of protection. The optimal timing of vaccination relative to treatment hasn’t been standardized yet, so talk to your provider about when to schedule it.
If You’re Pregnant
Pregnancy changes the management timeline but not the overall approach. If you have a positive high-risk HPV test during pregnancy, screening follows the same risk thresholds as for non-pregnant individuals. If colposcopy is needed, it’s considered safe during pregnancy, and biopsies can be performed when clinically indicated without increasing the risk of complications.
The key difference is that treatment procedures like LEEP are not performed during pregnancy unless cancer is actually suspected. This is because precancerous changes rarely progress during the relatively short window of a pregnancy, and spontaneous regression rates for pregnant patients are high. If high-grade changes (CIN 2 or 3) are found, you’ll be monitored with colposcopy and testing every 12 to 24 weeks throughout pregnancy. Definitive treatment or re-evaluation is then scheduled no sooner than four weeks after delivery.
What to Know About Partners
HPV is extremely common, and unlike other sexually transmitted infections, there is no medical recommendation to notify past sexual partners of a positive test. There’s no approved HPV test for men (outside of anal screening in certain populations), and most people with HPV never develop symptoms or health problems. Your current partner has very likely already been exposed to the same strain. Using condoms reduces transmission but doesn’t eliminate it, since HPV can spread through skin-to-skin contact in areas a condom doesn’t cover.
The most productive conversation to have with a partner isn’t about blame or timing of infection, which is usually impossible to determine. It’s about making sure both of you are up to date on vaccination if eligible and that you’re keeping up with your own recommended screenings.
Staying on Top of Follow-Up
The single most important thing you can do after a high-risk HPV diagnosis is keep every follow-up appointment. Whether your provider recommends a repeat test in one year, colposcopy, or post-treatment surveillance, these check-ins are what prevent a manageable situation from becoming a serious one. Cervical cancer develops slowly, and the screening and treatment tools available today are highly effective at catching changes long before they become dangerous. Your job is to show up.